Prednisone Administration in Quiescent COPD Patients to Determine the Effect on Gene Expression

NCT02534402 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Chronic Obstructive Pulmonary Disease

Interventions

DRUG: Prednisone

Sponsor

University of British Columbia